BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2017
View Archived Issues
Ionis Pharmaceuticals licenses second oral antisense drug to Janssen Biotech
Read More
Seattle Children's begins phase I study of CAR T-cell immunotherapy for CD19- and CD22-positive ALL
Read More
Bristol-Myers Squibb commences phase I/II trial of BMS-986251 for psoriasis
Read More
Aurigene and Orion identify lead compounds inhibiting protein arginine N-methyltransferase 5
Read More
First-in-human trial of affinity-enhanced TCR-gene transduced T-cell transfer targeting NY-ESO-1
Read More
Phase I results for AAV1 vectored immunoprophylaxis for HIV
Read More
FDA extends review period for Tlando NDA
Read More
Arginase-1/2 inhibitor OATD-02 a clinical candidate for cancer immunotherapy
Read More
FDA agrees on initial pediatric study plan for oral rimegepant
Read More
Phase III HAVEN 3 study of emicizumab in hemophilia A meets endpoints
Read More
NXT-596 demonstrates gamma-secretase inhibition as a therapeutic strategy against hearing loss
Read More
European Commission approves trastuzumab biosimilar Ontruzant
Read More
Novel molecule from Quadriga BioSciences shows promise for resistant glioblastoma
Read More
Phase III IMpower150 study of Tecentriq and Avastin in NSCLC meets PFS coprimary endpoint
Read More
Genoscience Pharma presents compounds for treating cancer
Read More
Rudong SIMR Biotech identifies novel GABRA5 inverse agonists
Read More
University of California, Oakland divulges erbB inhibitors
Read More
Sumitomo Dainippon Pharma discloses TLR7 antagonists
Read More
Galapagos reports topline results from phase II study of GLPG-2222 in cystic fibrosis
Read More
University of Texas System identifies novel sigma1/2 receptor modulators
Read More
European Commission approves Tasigna for pediatric Ph+ CML-CP
Read More
resTORbio advances phase IIb study of RTB-101 following recommendation of DMC
Read More
Umecrine initiates phase IIa study of GR-3027 in idiopathic hypersomnia
Read More
Celldex Therapeutics begins phase II study of CDX-3379 plus cetuximab
Read More
GlaxoSmithKline initiates first-in-human study of GSK-3511294 in mild to moderate asthma
Read More
Glenmark studies GBR-1342 for previously treated multiple myeloma in phase I study
Read More